Phyto Chem (I)

  • Market Cap: Micro Cap
  • Industry: Pesticides & Agrochemicals
  • ISIN: INE037C01010
  • NSEID:
  • BSEID: 524808
INR
20.00
0.2 (1.01%)
BSENSE

Sep 02, 03:30 PM

BSE+NSE Vol: 1.32 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

1.32 k (53.34%) Volume

Shareholding (Jun 2026)

FII

0.00%

Held by 0 FIIs

DII

0.19%

Held by 0 DIIs

Promoter

40.40%

Why is Phyto Chem (India) Ltd falling/rising?

03-Sep-2026

As of 02-Sep, Phyto Chem (India) Ltd's stock is rising to 20.00, up 1.01%, driven by recent outperformance and a 5.26% weekly gain. However, it has significant long-term declines, with a year-to-date drop of 29.70%, and concerns about reduced investor participation may affect future performance.

As of 02-Sep, Phyto Chem (India) Ltd's stock price is rising, currently at 20.00, with a change of 0.2 (1.01%) upwards. This increase can be attributed to the stock outperforming its sector by 0.39% today and having gained for the last three consecutive days, resulting in a total return of 2.04% during this period. Additionally, the stock has shown a positive performance over the past week, with a rise of 5.26%, while the benchmark Sensex has declined by 1.17% in the same timeframe.<BR><BR>However, it is important to note that despite the recent gains, the stock has experienced significant declines over longer periods, including a year-to-date drop of 29.70% and a one-year decline of 27.43%. The stock's current price is also higher than its 5-day and 20-day moving averages, indicating a short-term upward trend, although it remains below its longer-term moving averages (50-day, 100-day, and 200-day). <BR><BR>Despite the positive short-term performance, there are concerns regarding falling investor participation, as evidenced by a significant drop in delivery volume, which decreased by 82.49% against the 5-day average. This erratic trading pattern, along with the overall long-term decline, suggests that while the stock is currently rising, it faces challenges that could impact its future performance.

View full answer

Who are in the management team of Phyto Chem (I)?

01-Sep-2026

The management team of Phyto Chem (I) includes Chairman P Sreemannarayana, Managing Director Y Nayudamma, and several directors, including independent and alternate directors, responsible for the company's operations and strategic direction.

The management team of Phyto Chem (I) includes the following individuals:<BR><BR>1. **P Sreemannarayana** - Chairman (Non-Executive)<BR>2. **Y Nayudamma** - Managing Director<BR>3. **Y Venkateswarlu** - Director<BR>4. **P Anjaneyulu** - Director<BR>5. **Y Janaki Ramaiah** - Executive Director<BR>6. **Pavansingh Thakur** - Company Secretary & Compliance Officer<BR>7. **M Sreerama Murthy** - Independent Director<BR>8. **G S R Anjaneyulu** - Independent Director<BR>9. **Yugandhar Sampath Kumar Sakhamuri** - Independent Director<BR>10. **Vijitha Gorrepati** - Independent Director<BR>11. **K. Srinivasa Rao** - Alternate Director<BR>12. **N. Nagendra Naidu** - Independent Director<BR><BR>This team is responsible for overseeing the company's operations and strategic direction.

View full answer

What does Phyto Chem (I) do?

01-Sep-2026

Phyto Chem (India) Ltd manufactures and markets pesticides for the agriculture sector and has a market cap of INR 9 Cr. As of June 2026, it reported net sales of 0 Cr and a net profit of -1 Cr.

Overview: <BR>Phyto Chem (India) Ltd is engaged in the manufacturing and marketing of pesticides for the agriculture sector and operates within the Micro Cap category in the Pesticides & Agrochemicals industry.<BR><BR>History: <BR>Phyto Chem (India) Ltd was established in January 1989. The latest quarterly results reported net sales and net profit for the period ending June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: -1 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 9 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 26 <BR>Dividend Yield: 0.00% <BR>Debt Equity: 4.48 <BR>Return on Equity: -48.58% <BR>Price to Book: 1.84<BR><BR>Contact Details: <BR>Address: Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313 <BR>Tel: 91-8458-275236 <BR>Email: info@phytochemindia.com <BR>Website: http://www.phytochemindia.com

View full answer

Who are the peers of the Phyto Chem (I)?

01-Sep-2026

Peers of Phyto Chem (I) include Shivalik Rasayan, Super Crop Safe, Bhaskar Agrochem, Aimco Pesticides, Adarsh Plant, Dhansa Labs, Aristo Bio-Tech, and Crop Life Science. Super Crop Safe leads in 1-year return at 23.78%, while Phyto Chem (I) has a return of -29.94%.

Peers: The peers of Phyto Chem (I) are Shivalik Rasayan, Super Crop Safe, Bhaskar Agrochem, Aimco Pesticides, Adarsh Plant, Dhansa Labs, Aristo Bio-Tech, and Crop Life Scienc.<BR><BR>Quality Snapshot: Excellent management risk is observed at Shivalik Rasayan, while Average management risk is found at Aristo Bio-Tech and Crop Life Scienc, and the rest have Below Average management risk. Good growth is seen at Bhaskar Agrochem, while Average growth is present at Aristo Bio-Tech and Crop Life Scienc, and the rest have Below Average growth. Excellent capital structure is noted at Shivalik Rasayan, while Average capital structure is found at Aristo Bio-Tech and Crop Life Scienc, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Super Crop Safe at 23.78%, while the lowest is Aimco Pesticides at -40.26%, with Phyto Chem (I) having a 1-year return of -29.94%, which is better than Aimco Pesticides but worse than Super Crop Safe. Additionally, Dhansa Labs, Aristo Bio-Tech, and Crop Life Scienc all have a six-month return of 0.00%.

View full answer

How big is Phyto Chem (I)?

01-Sep-2026

As of 31st August, Phyto Chem (India) Ltd has a market capitalization of 9.00 Cr, with recent net sales of 7.59 Cr and a net profit loss of 2.22 Cr. The company reported shareholder's funds of 6.39 Cr and total assets of 27.30 Cr for the latest annual period ending in March 2025.

As of 31st August, Phyto Chem (India) Ltd has a market capitalization of 9.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Phyto Chem reported Net Sales of 7.59 Cr. However, the company experienced a Net Profit loss of 2.22 Cr during the same period.<BR><BR>For the latest annual period ending in March 2025, the company reported Shareholder's Funds of 6.39 Cr and Total Assets of 27.30 Cr.

View full answer

Should I buy, sell or hold Phyto Chem (India) Ltd?

16-Aug-2026

When is the next results date for Phyto Chem (India) Ltd?

07-Aug-2026

The next results date for Phyto Chem (India) Ltd is 13 August 2026.

The next results date for Phyto Chem (India) Ltd is scheduled for 13 August 2026.

View full answer

Are Phyto Chem (India) Ltd latest results good or bad?

02-Jun-2026

Phyto Chem (India) Ltd's latest results are concerning, showing a net loss of ₹0.28 crores for Q4 FY26, with revenue plummeting 84.25% year-over-year and 92.26% from the previous quarter. The company faces significant operational challenges, reflected in a negative operating margin and return on equity, indicating a negative outlook.

The latest results for Phyto Chem (India) Ltd are quite concerning. In the fourth quarter of FY26, the company reported a net loss of ₹0.28 crores, marking its fourth consecutive quarter of losses. Revenue has drastically declined to ₹0.23 crores, which represents an alarming 84.25% decrease compared to the same quarter last year and a staggering 92.26% drop from the previous quarter.<BR><BR>The operating margin is severely negative at -282.61%, indicating that the company's fixed costs far exceed its revenue generation capacity. Additionally, the return on equity (ROE) stands at -50.00%, reflecting significant capital destruction and raising serious questions about the sustainability of its business model.<BR><BR>Overall, these results paint a grim picture of a company in distress, struggling to maintain operational viability in a challenging market environment. The combination of collapsing revenue, mounting losses, and negative profitability metrics suggests that the outlook for Phyto Chem is quite negative at this time.

View full answer

How has been the historical performance of Phyto Chem (I)?

01-Dec-2025

Phyto Chem (I) has shown a declining trend in net sales and profitability, with net sales dropping from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25, resulting in significant losses and negative operating profit. The company's financial health has deteriorated, reflected in increasing losses and stagnant cash flow.

Answer:<BR>The historical performance of Phyto Chem (I) shows a declining trend in net sales and profitability over the years, with significant losses reported in the most recent fiscal year.<BR><BR>Breakdown:<BR>Phyto Chem (I) has experienced a consistent decline in net sales, dropping from 44.49 Cr in Mar'21 to just 14.08 Cr in Mar'25. This decline is mirrored in total operating income, which also fell from 44.49 Cr in Mar'21 to 14.08 Cr in Mar'25. The company's total expenditure has decreased from 42.28 Cr in Mar'21 to 15.42 Cr in Mar'25, yet it remains higher than the operating income, resulting in an operating profit (PBDIT) that has turned negative, reaching -1.34 Cr in Mar'25. Profit before tax has similarly worsened, moving from a profit of 0.47 Cr in Mar'21 to a loss of 1.05 Cr in Mar'25, leading to a profit after tax of -0.99 Cr for the same period. The earnings per share have also deteriorated, showing a loss of -2.3 in Mar'25 compared to a profit of 1.14 in Mar'21. On the balance sheet, total liabilities have decreased from 67.59 Cr in Mar'20 to 27.30 Cr in Mar'25, while total assets have similarly declined from 67.59 Cr to 27.30 Cr over the same period. The company has reported no cash inflow or outflow in recent years, indicating a stagnant cash position. Overall, Phyto Chem (I) has faced significant challenges, reflected in its declining sales, increasing losses, and deteriorating financial health.

View full answer

Is Phyto Chem (I) overvalued or undervalued?

09-Jun-2025

As of May 30, 2024, Phyto Chem (I) is considered risky and overvalued, with poor financial ratios indicating negative earnings performance and significant underperformance compared to industry peers and the Sensex.

As of 30 May 2024, the valuation grade for Phyto Chem (I) has moved from attractive to risky, indicating a significant deterioration in its financial standing. The company is currently assessed as overvalued. Key ratios reveal a PE ratio of -12.21, an EV to EBITDA of -22.40, and a ROE of -13.59%, all of which suggest poor profitability and negative earnings performance.<BR><BR>In comparison to its peers, Phyto Chem (I) stands out unfavorably; for instance, P I Industries has a PE ratio of 35.59, while UPL boasts a PE ratio of 38.74, both indicating a much stronger valuation. The negative ratios and the shift in valuation grade highlight that Phyto Chem (I) is not only underperforming relative to its industry peers but also reflects a concerning trend in its financial health. Additionally, the company's stock has underperformed the Sensex over various time frames, including a year-to-date decline of 17.85% compared to the Sensex's gain of 5.63%.

View full answer

What is the technical trend for Phyto Chem (I)?

09-Jun-2025

As of May 27, 2025, Phyto Chem (I) has a bearish technical trend, supported by negative MACD indicators and moving averages, while the RSI shows no momentum and Dow Theory indicates no clear trend.

As of 27 May 2025, the technical trend for Phyto Chem (I) has changed from mildly bearish to bearish. The weekly and monthly MACD indicators are both bearish, reinforcing the negative sentiment. The daily moving averages also indicate a bearish stance. Although the Bollinger Bands show a mildly bearish trend on both weekly and monthly time frames, the KST is bearish as well. The RSI shows no signal, indicating a lack of momentum in either direction. Dow Theory confirms no trend on both weekly and monthly levels. Overall, the current technical stance is bearish with a moderate strength, driven primarily by the bearish MACD and moving averages.

View full answer

Who are the top shareholders of the Phyto Chem (I)?

06-Jun-2025

The top shareholder of Phyto Chem (I) is promoter Nayudamma Yarlagadda, holding 7.87%. Individual investors own 49.29% of the shares, with no pledged promoter holdings or foreign institutional investors involved.

The top shareholders of Phyto Chem (I) include Nayudamma Yarlagadda, who is the promoter with the highest holding at 7.87%. The majority of the shareholding is held by individual investors, accounting for 49.29% of the shares. There are no pledged promoter holdings, and the company has no foreign institutional investors (FIIs) involved. Additionally, two mutual fund schemes hold a small portion of shares, totaling 0.19%.

View full answer

Has Phyto Chem (I) declared dividend?

06-Jun-2025

Phyto Chem (India) Ltd has declared a 10% dividend, amounting to ₹1.00 per share, with an ex-date of September 25, 2014. However, the dividend yield is 0%, and total returns over recent periods have been largely negative, except for the 3-year and 4-year spans.

Phyto Chem (India) Ltd has declared a 10% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 10%<BR>- Amount per share: 1.0000<BR>- Ex-date: 25 Sep 14<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -22.7%, the dividend return was 0%, resulting in a total return of -22.7%.<BR><BR>For the 1-year period, the price return was -8.67%, the dividend return was 0%, leading to a total return of -8.67%.<BR><BR>Over the 2-year period, the price return was -21.4%, with a dividend return of 0%, resulting in a total return of -21.4%.<BR><BR>In the 3-year period, the price return was 29.15%, the dividend return was 0%, which resulted in a total return of 29.15%.<BR><BR>For the 4-year period, the price return was 22.81%, the dividend return was 0%, leading to a total return of 22.81%.<BR><BR>In the 5-year period, the price return was -4.81%, with a dividend return of 0%, resulting in a total return of -4.81%.<BR><BR>Overall, while Phyto Chem (India) Ltd has declared a dividend, the total returns over various periods show significant fluctuations, with negative returns in most periods except for the 3-year and 4-year spans. The dividend yield remains at 0%, indicating that the dividend has not contributed to the overall returns in recent years.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -24.76% and Operating profit at -209.99% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) of 2.62 times
  • The company has been able to generate a Return on Equity (avg) of 0.88% signifying low profitability per unit of shareholders funds
2

Flat results in Jun 26

3

Risky - Negative EBITDA

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pesticides & Agrochemicals

stock-summary
Market cap

INR 9 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

26

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

4.48

stock-summary
Return on Equity

-48.58%

stock-summary
Price to Book

1.86

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Jun 2026)
Net Profit:
-1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-23.08%
0%
-23.08%
6 Months
-18.2%
0%
-18.2%
1 Year
-27.43%
0%
-27.43%
2 Years
-29.45%
0%
-29.45%
3 Years
-54.65%
0%
-54.65%
4 Years
21.58%
0%
21.58%
5 Years
-2.68%
0%
-2.68%

Latest dividend: 1.0000 per share ex-dividend date: Sep-25-2014

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

14-Aug-2026 | Source : BSE

Pursuant to Regulation 47 of the SEBI (LODR) Regulations 2015 please find enclosed copies of the newspaper advertisement pertaining Unaudited Financial Results of the Company for the First Quarter ended June 30 2026. The advertisements were published in Business Standard (English) and Andhra Prabha (Telugu) on August 14 2026. This is your information and records.

Results-Financial Results For June 30 2026 (Submission Of Unaudited Financial Results Of The Company For The First Quarter Ended 30Th June 2026 - In Compliance Of Regulation 33 Of The SEBI (LODR) Regulations 2015 - Reg.

13-Aug-2026 | Source : BSE

In Furtherance to the Board meeting notice dt:06-08-2026 we wish to inform you that at the meeting of Board of Directors of M/s.Phyto Chem (India) Limited held today i.e. on 13-08-2026 the Board has inter-alia considered and approved the Unaudited Financial Results for the First Quarter ended 30-06-2026. The said Unaudited Financial Results for reviewed by the Audit Committee and thereafter approved by the Board.

Board Meeting Outcome for Outcome Of Board Meeting- In Compliance Of Regulation 30(6) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Regarding.

13-Aug-2026 | Source : BSE

Pursuant to the provisions of Reg. 30(6) of the SEBI (LODR) Reg. 2015 we would like to inform you that at the meeting of Board of Directors of M/s Phyto Chem (India) Limited held on 13-08-26 the Board has approved inter-alia the following items: 1. Approved the Unaudited Financial Results of the company for the 1st Quarter ended 30-06-26. 2. Approved the re-appointment of M/s R. B. Associates. Chartered Accountants as the Internal Auditors of the Company for the F.Y. 2026-27. 3. Approved the Directors Report and Report on Corporate Governance Notice and Appointment of Scrutinizer for the F.Y. 2025-26. 4. Approved the Date and Venue Dates for Book Closure and cut off dates and e-voting system for 37th AGM of the Company. 5. Approved to lease out spare manufacturing facilities for effective utilisation. The details required under Reg. 30 of the LODR read with as per SEBI Circular are provided in Annexure-A to this letter.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Phyto Chem (India) Ltd has declared 10% dividend, ex-date: 25 Sep 14

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
-24.76%
EBIT Growth (5y)
-209.99%
EBIT to Interest (avg)
-0.44
Debt to EBITDA (avg)
2.68
Net Debt to Equity (avg)
4.48
Sales to Capital Employed (avg)
0.84
Tax Ratio
2.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.19%
ROCE (avg)
-4.07%
ROE (avg)
0.88%

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
26
Price to Book Value
1.88
EV to EBIT
-13.09
EV to EBITDA
-15.63
EV to Capital Employed
1.16
EV to Sales
3.83
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-8.83%
ROE (Latest)
-48.58%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 2 Schemes (0.19%)

FIIs

Held by 0 FIIs

Promoter with highest holding

Nayudamma Yarlagadda (7.87%)

Highest Public shareholder

None

Individual Investors Holdings

49.64%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -98.00% vs -67.46% in Jun 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2026 is -87.50% vs 67.35% in Jun 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.03",
          "val2": "1.50",
          "chgp": "-98.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.52",
          "val2": "-0.51",
          "chgp": "-1.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.36",
          "val2": "0.33",
          "chgp": "9.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.90",
          "val2": "-0.48",
          "chgp": "-87.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,733.33%",
          "val2": "-34.00%",
          "chgp": "-1,699.33%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5.87",
          "val2": "8.98",
          "chgp": "-34.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.96",
          "val2": "-0.46",
          "chgp": "-108.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.67",
          "val2": "0.76",
          "chgp": "-11.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.04",
          "val2": "-1.36",
          "chgp": "23.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-16.35%",
          "val2": "-5.12%",
          "chgp": "-11.23%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -30.01% vs -12.11% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1,050.00% vs 109.82% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8.84",
          "val2": "12.63",
          "chgp": "-30.01%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.21",
          "val2": "-0.29",
          "chgp": "-317.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.14",
          "val2": "1.28",
          "chgp": "-10.94%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.52",
          "val2": "0.16",
          "chgp": "-1,050.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-13.69%",
          "val2": "-2.30%",
          "chgp": "-11.39%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is -35.58% vs -4.93% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -81.82% vs 70.27% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9.07",
          "val2": "14.08",
          "chgp": "-35.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.86",
          "val2": "-1.34",
          "chgp": "-38.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "1.84",
          "chgp": "-18.48%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.80",
          "val2": "-0.99",
          "chgp": "-81.82%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-20.51%",
          "val2": "-9.52%",
          "chgp": "-10.99%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Jun'26 - YoYstock-summary

Jun'26
Jun'25
Change(%)
Net Sales
0.03
1.50
-98.00%
Operating Profit (PBDIT) excl Other Income
-0.52
-0.51
-1.96%
Interest
0.36
0.33
9.09%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.90
-0.48
-87.50%
Operating Profit Margin (Excl OI)
-1,733.33%
-34.00%
-1,699.33%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2026 is -98.00% vs -67.46% in Jun 2025

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Jun 2026 is -87.50% vs 67.35% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
5.87
8.98
-34.63%
Operating Profit (PBDIT) excl Other Income
-0.96
-0.46
-108.70%
Interest
0.67
0.76
-11.84%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.04
-1.36
23.53%
Operating Profit Margin (Excl OI)
-16.35%
-5.12%
-11.23%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is -34.63% vs 14.39% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 23.53% vs 29.17% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
8.84
12.63
-30.01%
Operating Profit (PBDIT) excl Other Income
-1.21
-0.29
-317.24%
Interest
1.14
1.28
-10.94%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.52
0.16
-1,050.00%
Operating Profit Margin (Excl OI)
-13.69%
-2.30%
-11.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is -30.01% vs -12.11% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1,050.00% vs 109.82% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
9.07
14.08
-35.58%
Operating Profit (PBDIT) excl Other Income
-1.86
-1.34
-38.81%
Interest
1.50
1.84
-18.48%
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.80
-0.99
-81.82%
Operating Profit Margin (Excl OI)
-20.51%
-9.52%
-10.99%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is -35.58% vs -4.93% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -81.82% vs 70.27% in Mar 2025

stock-summaryCompany CV
About Phyto Chem (India) Ltd stock-summary
stock-summary
Phyto Chem (India) Ltd
Micro Cap
Pesticides & Agrochemicals
Phyto Chem (India) Limited was established in January, 1989 and is into the business of manufacturing & marketing of pesticides for agriculture sector. The Company is presently carrying on the business in three segments i.e. Pesticides Formulations, Ferro Alloy Products and Real Estate.
Company Coordinates stock-summary
Company Details
Survey No 628 Temple Street, Jinnaram Mandal Bonthapally Medak Telangana : 502313
stock-summary
Tel: 91-8458-275236
stock-summary
info@phytochemindia.com
Registrar Details
Bigshare Services Pvt Ltd , 306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital, Raj Bhavan Road, Somajiguda, Hyderabad